Regeneron Pharmaceuticals, Inc.REGNNASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 83% recommend buying.

Consensus Rating

Buy

23 analysts·High coverage

83%

Rating Distribution

Strong Buy

00%

Buy

1983%

Hold

417%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 1% above analyst consensus — near fair value expected.

Bear Case

$584.00

-27%

Consensus

$790.59

-1%

Bull Case

$1057.00

+33%

Price Range23 analysts

Low

Consensus

High

$584.00

$1057.00

Current Target

Current Price

$796.55

Above Target

$5.96

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$45.49(9 analysts)

P/E18x

Current: 18.0x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+8.89%

EPS+16.59%

FY2028

Rev+7.27%

EPS+8.74%

FY2029

Rev+6.56%

EPS+8.53%

Earnings Surprises

Beat rate:83%(10/12 quarters)

Avg surprise:+12.1%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 8, 2026Goldman Sachs

Regeneron price target raised to $914 from $807 at Goldman Sachs

Target:$914.00

+12.5%from $812.27

Dec 17, 2025Leerink Partners

Regeneron Pharma (REGN) PT Raised to $873 at Leerink Partners

Target:$873.00

+17.0%from $746.36

Dec 12, 2025Morgan Stanley

Regeneron price target raised to $768 from $767 at Morgan Stanley

Target:$768.00

+3.6%from $741.51

Dec 10, 2025HSBC

Regeneron price target raised to $985 from $890 at HSBC

Target:$985.00

+42.2%from $692.58

Dec 4, 2025BMO Capital

Regeneron price target raised to $850 from $725 at BMO Capital

Target:$850.00

+17.5%from $723.67

Dec 4, 2025Canaccord Genuity

Regeneron price target raised to $1,057 from $850 at Canaccord

Target:$1057.00

+46.1%from $723.67

Nov 24, 2025Truist Financial

Regeneron assumed with a Buy at Truist

Target:$798.00

+4.1%from $766.50

Nov 24, 2025Scotiabank

Regeneron price target raised to $770 from $650 at Scotiabank

Target:$770.00

+0.1%from $769.23

Nov 24, 2025HSBC

Regeneron initiated with a Buy at HSBC

Target:$890.00

+17.7%from $755.90

Nov 20, 2025Wells Fargo

Regeneron price target raised to $700 from $615 at Wells Fargo

Target:$700.00

-0.4%from $702.75

Oct 29, 2025RBC Capital

Regeneron price target raised to $708 from $704 at RBC Capital

Target:$708.00

+8.4%from $653.01

Oct 29, 2025Cantor Fitzgerald

Regeneron Pharma (REGN) PT Raised to $740 at Cantor Fitzgerald

Target:$740.00

+12.6%from $657.00

Oct 29, 2025BMO Capital

Regeneron price target raised to $725 from $640 at BMO Capital

Target:$725.00

+10.8%from $654.48

Oct 29, 2025Wells Fargo

Regeneron price target raised to $615 from $580 at Wells Fargo

Target:$615.00

-6.0%from $654.48

Oct 29, 2025Robert W. Baird

Regeneron price target raised to $637 from $587 at Baird

Target:$637.00

-1.4%from $645.93

Oct 29, 2025Bernstein

Regeneron price target raised to $818 from $781 at Bernstein

Target:$818.00

+25.0%from $654.42

Oct 29, 2025Guggenheim

Regeneron price target raised to $865 from $815 at Guggenheim

Target:$865.00

+32.2%from $654.48

Oct 29, 2025Robert W. Baird

Regeneron Pharma (REGN) PT Raised to $630 at Baird

Target:$630.00

-3.7%from $654.48

Oct 28, 2025Raymond James

Regeneron price target raised to $723 from $673 at Raymond James

Target:$723.00

+10.5%from $654.48

Oct 28, 2025Morgan Stanley

Regeneron price target raised to $767 from $756 at Morgan Stanley

Target:$767.00

+17.2%from $654.48

Oct 10, 2025Morgan Stanley

Regeneron price target lowered to $756 from $761 at Morgan Stanley

Target:$756.00

+32.9%from $568.81

Sep 2, 2025Raymond James

Regeneron assumed with Outperform from Market Perform at Raymond James

Target:$673.00

+16.5%from $577.90

Aug 4, 2025BMO Capital

Regeneron price target raised to $640 from $600 at BMO Capital

Target:$640.00

+12.0%from $571.54

Aug 1, 2025Wells Fargo

Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Target:$580.00

+2.9%from $563.43

Aug 1, 2025Citigroup

Regeneron Pharmaceuticals Likely To Report Lower Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Target:$650.00

+15.4%from $563.43

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance